Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia (original) (raw)

• Letter
• Published: 19 February 1998
• Silvia De Matteis1,
• Clara Nervi3,
• Lucia Tomassoni4,
• Vania Gelmetti1,
• Mario Cioce4,
• Mirco Fanelli4,
• Marthin Ruthardt5,
• Fabiana F. Ferrara3,
• Iris Zamir6,
• Christian Seiser7,
• Fausto Grignani1,
• Mitchell A. Lazar6,
• Saverio Minucci4 &
• …
• Pier Giuseppe Pelicci1,4

Nature volume 391, pages 815–818 (1998)Cite this article

• 2182 Accesses
• 900 Citations
• 6 Altmetric
• Metrics details

Abstract

The transforming proteins of acute promyelocytic leukaemias (APL) are fusions of the promyelocytic leukaemia (PML) and the promyelocytic leukaemia zinc-finger (PLZF) proteins with retinoic acid receptor-α (RARα)1,2. These proteins retain the RARα DNA- and retinoic acid (RA)-binding domains, and their ability to block haematopoietic differentiation depends on the RARα DNA-binding domain3,4,5,6. Thus RA-target genes are downstream effectors7,8. However, treatment with RA induces differentiation of leukaemic blast cells and disease remission in PML–RARα APLs, whereas PLZF–RARα APLs are resistant to RA1,2. Transcriptional regulation by RARs involves modifications of chromatin by histone deacetylases, which are recruited to RA-target genes by nuclear co-repressors9,10. Here we show that both PML–RARα and PLZF–RARα fusion proteins recruit the nuclear co-repressor (N-CoR)–histone deacetylase complex through the RARα CoR box. PLZF–RARα contains a second, RA-resistant binding site in the PLZF amino-terminal region. High doses of RA release histone deacetylase activity from PML–RARα, but not from PLZF–RARα. Mutation of the N-CoR binding site abolishes the ability of PML–RARα to block differentiation, whereas inhibition of histone deacetylase activity switches the transcriptional and biological effects of PLZF–RARα from being an inhibitor to an activator of the RA signalling pathway. Therefore, recruitment of histone deacetylase is crucial to the transforming potential of APL fusion proteins, and the different effects of RA on the stability of the PML–RARα and PLZF–RARα co-repressor complexes determines the differential response of APLs to RA.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

References

1. Grignani, F. et al. Acute promyelocytic leukaemia: from genetics to treatment. Blood 83, 10–25 (1994).
   CAS PubMed Google Scholar
2. Warrell, R. P. J., de Thé, H., Wang, Z. Y. & Degos, L. Acute promyelocytic leukaemia. N. Engl. J. Med. 324, 177–189 (1993).
   Article Google Scholar
3. de The, H. et al. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675–684 (1991).
   Article CAS PubMed Google Scholar
4. Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663–674 (1991).
   Article CAS PubMed Google Scholar
5. Pandolfi, P. P. et al. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J. 11, 1397–1407 (1992).
   Article CAS PubMed PubMed Central Google Scholar
6. Chen, Z. et al. Fusion between a novel Krüppel-like zinc finger gene and retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12, 1161–1167 (1993).
   Article CAS PubMed PubMed Central Google Scholar
7. Chen, Z. et al. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid recetors. Proc. Natl Acad. Sci. USA 91, 1178–1182 (1994).
   Article ADS CAS PubMed PubMed Central Google Scholar
8. Ruthardt, M. et al. Opposite effects of the Acute Promyelocytic Leukaemia PML/RARα and PLZF/RARα fusion proteins on retinoic acid signalling. Mol. Cell. Biol. 17, 4859–4869 (1997).
   Article CAS PubMed PubMed Central Google Scholar
9. Heinzel, T. et al. Acomplex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43–49 (1997).
   Article ADS CAS PubMed Google Scholar
10. Nagy, L. et al. Nuclear receptor repression mediated by a complex containing SMRT,,mSin3A, and histone deacetylase. Cell 89, 373–380 (1997).
    Article CAS PubMed Google Scholar
11. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349–352 (1997).
    Article ADS CAS PubMed Google Scholar
12. Wolffe, A. P. Sinful repression. Nature 387, 16–17 (1997).
    Article ADS CAS PubMed Google Scholar
13. Mangelsdorf, D. J. & Evans, R. M. The RXR heterodimers and orphan receptors. Cell 83, 841–850 (1995).
    Article CAS PubMed Google Scholar
14. Minucci, S. & Ozato, K. Retinoid receptors in transcriptional regulation. Curr. Opin. Genet. Dev. 6, 567–574 (1996).
    Article CAS PubMed Google Scholar
15. Chambon, P. Adecade of molecular biology of retinoid receptors. FASEB J. 10, 940–954 (1996).
    Article CAS PubMed Google Scholar
16. Hong, S., David, G., Wong, C., Dejean, A. & Privalsky, M. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha and PLZF-RAR alpha oncoproteins associated with acute promyelocytic leukaemia. Proc. Natl Acad. Sci. USA 94, 9028–9033 (1997).
    Article ADS CAS PubMed PubMed Central Google Scholar
17. Grignani, F. et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423–431 (1993).
    Article CAS PubMed Google Scholar
18. Grignani, F. et al. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J. 15, 4949–4958 (1996).
    Article CAS PubMed PubMed Central Google Scholar
19. Horlein, A. J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397–403 (1995).
    Article ADS CAS PubMed Google Scholar
20. Dhordain, P. et al. SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl Acad. Sci. USA 94, 10727–10767 (1997).
    Article Google Scholar
21. Yoshida, M., Kijima, M., Akita, M. & Beppu, T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174–17179 (1990).
    CAS PubMed Google Scholar
22. Nagy, L. et al. Identification and characterization of a versatile retinoid response element in the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 271, 4355–4365 (1996).
    Article CAS PubMed Google Scholar
23. Benedetti, L. et al. Retinoic-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87, 1939–1950 (1996).
    CAS PubMed Google Scholar
24. Borrow, J. et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the REB-binding protein. Nature Genet. 14, 33–41 (1996).
    Article ADS CAS PubMed Google Scholar
25. Zamir, I. et al. Anuclear hormone receptor coreceptor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16, 5458–5465 (1996).
    Article CAS PubMed PubMed Central Google Scholar
26. Nervi, C. et al. Characterisation of the PML/RAR chimeric product of the APL-specific t(15;17) translocation. Cancer Res. 52, 3687–3692 (1992).
    CAS PubMed Google Scholar
27. Bartl, S. et al. Identification of mouse histone deacetylase I as a growth-factor inducible gene. Mol. Cell. Biol. 17, 5033–5043 (1997).
    Article CAS PubMed PubMed Central Google Scholar
28. Sundstrom, C. & Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17, 565–577 (1976).
    Article CAS PubMed Google Scholar
29. Lin, R. J. et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391, 811–814 (1998).
    Article ADS CAS PubMed Google Scholar

Download references

Acknowledgements

We thank P. P. DiFiore, K. Ozato, K. Helin, T. Casini and M. Maccarana for discussions, and C. Matteucci, S. DiPietro and S. Lupo for technical help. S.D.M., V.G. and M.F. are recipients of fellowships from A.U.L.L., A.I.R.C. and INT (Milan), respectively.

Author information

Authors and Affiliations

1. Istituto di Medicina Interna e Scienze Oncologiche, Perugia University, 06100, Perugia, Italy
   Francesco Grignani, Silvia De Matteis, Vania Gelmetti, Fausto Grignani & Pier Giuseppe Pelicci
2. Department of Haematology and Oncology, Istituto Superiore di Sanità, 00161, Rome, Italy
   Francesco Grignani
3. Dipartimento di Istologia ed Embriologia Medica, University of Rome La Sapienza, 00161, Rome, Italy
   Clara Nervi & Fabiana F. Ferrara
4. Department of Experimental Oncology, European Institute of Oncology, 20141, Milan, Italy
   Lucia Tomassoni, Mario Cioce, Mirco Fanelli, Saverio Minucci & Pier Giuseppe Pelicci
5. Division of Endocrinology, Department of Medicine and Department of Genetics, Diabetes and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, 19104, Pennsylvania, USA
   Marthin Ruthardt
6. Institute of Molecular Biology, Unviersity of Vienna, Vienna Biocenter, Vienna, Austria
   Iris Zamir & Mitchell A. Lazar
7. Department of Haematology, Johann Wolfgang Goethe-University, Frankfurt, Germany
   Christian Seiser

Authors

1. Francesco Grignani
   You can also search for this author inPubMed Google Scholar
2. Silvia De Matteis
   You can also search for this author inPubMed Google Scholar
3. Clara Nervi
   You can also search for this author inPubMed Google Scholar
4. Lucia Tomassoni
   You can also search for this author inPubMed Google Scholar
5. Vania Gelmetti
   You can also search for this author inPubMed Google Scholar
6. Mario Cioce
   You can also search for this author inPubMed Google Scholar
7. Mirco Fanelli
   You can also search for this author inPubMed Google Scholar
8. Marthin Ruthardt
   You can also search for this author inPubMed Google Scholar
9. Fabiana F. Ferrara
   You can also search for this author inPubMed Google Scholar
10. Iris Zamir
    You can also search for this author inPubMed Google Scholar
11. Christian Seiser
    You can also search for this author inPubMed Google Scholar
12. Fausto Grignani
    You can also search for this author inPubMed Google Scholar
13. Mitchell A. Lazar
    You can also search for this author inPubMed Google Scholar
14. Saverio Minucci
    You can also search for this author inPubMed Google Scholar
15. Pier Giuseppe Pelicci
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toPier Giuseppe Pelicci.

Rights and permissions

About this article

Cite this article

Grignani, F., De Matteis, S., Nervi, C. et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia.Nature 391, 815–818 (1998). https://doi.org/10.1038/35901

Download citation

• Received: 28 October 1997
• Accepted: 18 December 1997
• Issue Date: 19 February 1998
• DOI: https://doi.org/10.1038/35901

This article is cited by